Boris Pasche

10.0k total citations · 2 hit papers
122 papers, 5.9k citations indexed

About

Boris Pasche is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Boris Pasche has authored 122 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 57 papers in Molecular Biology and 27 papers in Pathology and Forensic Medicine. Recurrent topics in Boris Pasche's work include TGF-β signaling in diseases (30 papers), Genetic factors in colorectal cancer (25 papers) and Pancreatic and Hepatic Oncology Research (22 papers). Boris Pasche is often cited by papers focused on TGF-β signaling in diseases (30 papers), Genetic factors in colorectal cancer (25 papers) and Pancreatic and Hepatic Oncology Research (22 papers). Boris Pasche collaborates with scholars based in United States, China and Switzerland. Boris Pasche's co-authors include John Varga, Yanfei Xu, Virginia Kaklamani, Loren S. Michel, Michael J. Pennison, Naresh Bellam, Paul J. Grippo, William L. Gerald, Vundavalli V. Murty and Robert Benezra and has published in prestigious journals such as Nature, Science and JAMA.

In The Last Decade

Boris Pasche

116 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells

2001 610 citations Boris Pasche et al. profile →
TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis

2014 429 citations Daniel R. Principe, Hidayatullah G. Munshi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Boris Pasche United States	40	3.0k	2.1k	1.2k	963	793	122	5.9k
Mark A. Watson United States	48	3.4k 1.1×	1.9k 0.9×	1.7k 1.4×	794 0.8×	1.4k 1.8×	129	7.2k
Giuseppe Viglietto Italy	48	5.4k 1.8×	2.3k 1.1×	1.6k 1.3×	591 0.6×	803 1.0×	150	8.2k
Toshiyuki Ishiwata Japan	47	3.6k 1.2×	2.5k 1.2×	1.4k 1.2×	387 0.4×	586 0.7×	215	6.4k
Vladimir Lazar France	46	4.1k 1.3×	2.1k 1.0×	2.1k 1.7×	607 0.6×	954 1.2×	133	7.4k
Dilip D. Giri United States	37	3.0k 1.0×	2.9k 1.4×	2.4k 2.0×	1.1k 1.1×	712 0.9×	94	7.0k
Colin A. Purdie United Kingdom	35	2.8k 0.9×	3.3k 1.6×	1.8k 1.5×	932 1.0×	552 0.7×	92	6.5k
Kwok Wah Chan Hong Kong	46	3.2k 1.0×	2.5k 1.2×	1.7k 1.4×	687 0.7×	945 1.2×	162	8.0k
Fei Huang China	35	3.2k 1.1×	1.7k 0.8×	1.5k 1.2×	575 0.6×	711 0.9×	190	6.5k
Carl Morrison United States	45	4.2k 1.4×	2.3k 1.1×	2.4k 2.0×	922 1.0×	1.3k 1.6×	185	8.1k
Jacob Pe’er Israel	39	3.6k 1.2×	1.8k 0.8×	1.2k 1.0×	336 0.3×	658 0.8×	149	7.7k

Countries citing papers authored by Boris Pasche

Since Specialization

Citations

This map shows the geographic impact of Boris Pasche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Pasche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Pasche more than expected).

Fields of papers citing papers by Boris Pasche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Pasche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Pasche. The network helps show where Boris Pasche may publish in the future.

Co-authorship network of co-authors of Boris Pasche

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Pasche. A scholar is included among the top collaborators of Boris Pasche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Pasche. Boris Pasche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Choucair, Khalil, Md. Hafiz Uddin, Misako Nagasaka, et al.. (2025). Targeting KRAS mutations: orchestrating cancer evolution and therapeutic challenges. Signal Transduction and Targeted Therapy. 10(1). 385–385. 2 indexed citations

Aboukameel, Amro, Husain Yar Khan, Md. Hafiz Uddin, et al.. (2024). RCC1 regulation of subcellular protein localization via Ran GTPase drives pancreatic ductal adenocarcinoma growth. Cancer Letters. 604. 217275–217275. 2 indexed citations

Sohl, Stephanie J., Pamela W. Duncan, John M. Salsman, et al.. (2022). Adaptation of a Personalized Electronic Care Planning Tool for Cancer Follow-up Care: Formative Study. JMIR Formative Research. 7. e41354–e41354.

Chang, Antao, Liang Liu, Dan Wu, et al.. (2021). Recruitment of KMT2C/MLL3 to DNA Damage Sites Mediates DNA Damage Responses and Regulates PARP Inhibitor Sensitivity in Cancer. Cancer Research. 81(12). 3358–3373. 39 indexed citations

Jatoi, Aminah, Fang‐Shu Ou, Daniel H. Ahn, et al.. (2021). Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial. The Oncologist. 26(7). 610–618. 5 indexed citations

Gmeiner, William H., David L. Caudell, Ralph B. D’Agostino, et al.. (2020). Improved Antitumor Activity of the Fluoropyrimidine Polymer CF10 in Preclinical Colorectal Cancer Models through Distinct Mechanistic and Pharmacologic Properties. Molecular Cancer Therapeutics. 20(3). 553–563. 14 indexed citations

Rimkus, Tadas, Richard L. Carpenter, Sherona Sirkisoon, et al.. (2018). Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44. Cancer Research. 78(10). 2589–2600. 32 indexed citations

Xing, Fei, Yin Liu, Shih-Ying Wu, et al.. (2018). Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis. Cancer Research. 78(15). 4316–4330. 259 indexed citations

Xing, Fei, Yin Liu, Sambad Sharma, et al.. (2016). Activation of the c-Met Pathway Mobilizes an Inflammatory Network in the Brain Microenvironment to Promote Brain Metastasis of Breast Cancer. Cancer Research. 76(17). 4970–4980. 102 indexed citations

10.

Principe, Daniel R., Brian DeCant, Emman Mascariñas, et al.. (2016). TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis. Cancer Research. 76(9). 2525–2539. 156 indexed citations

11.

Costa, Frederico, et al.. (2012). Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours. Best Practice & Research Clinical Gastroenterology. 26(6). 843–854. 9 indexed citations

12.

Kaklamani, Virginia, Nengjun Yi, Kui Zhang, et al.. (2011). Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism. 60(9). 1234–1243. 47 indexed citations

13.

Zeng, Qinghua, Yanfei Xu, Maureen Sadim, et al.. (2009). Tgfbr1 Haploinsufficiency Is a Potent Modifier of Colorectal Cancer Development. Cancer Research. 69(2). 678–686. 45 indexed citations

14.

Strouch, Matthew J., Qinghua Zeng, Morgan R. Barron, et al.. (2009). Tgfbr1 Haploinsufficiency Inhibits the Development of Murine Mutant Kras -Induced Pancreatic Precancer. Cancer Research. 69(24). 9169–9174. 27 indexed citations

15.

Lei, Zhe, Rengyun Liu, Jun Zhao, et al.. (2009). TGFBR1 Haplotypes and Risk of Non–Small-Cell Lung Cancer. Cancer Research. 69(17). 7046–7052. 22 indexed citations

16.

Barbault, Alexandre, et al.. (2009). Amplitude-modulated electromagnetic fields for the treatment of cancer: Discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. Journal of Experimental & Clinical Cancer Research. 28(1). 51–51. 109 indexed citations

17.

Valle, Laura, Sandya Liyanarachchi, Heather Hampel, et al.. (2008). Germline Allele-Specific Expression of TGFBR1 Confers an Increased Risk of Colorectal Cancer. Science. 321(5894). 1361–1365. 107 indexed citations

18.

Patel, Jyoti D., Boris Pasche, & Athanassios Argiris. (2004). Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we go. Critical Reviews in Oncology/Hematology. 50(3). 175–186. 7 indexed citations

19.

Elgue, Graciela, Boris Pasche, Margareta Blombäck, & Per Olsson. (1990). The Use of a Commercial ELISA for Assay of Thrombin-Antithrombin Complexes in Purified Systems. Thrombosis and Haemostasis. 63(3). 435–438. 10 indexed citations

20.

Pasche, Boris, Koichi Kodama, Olle Larm, Per Olsson, & Jesper Swedenborg. (1986). Thrombin inactivation on surfaces with covalently bonded heparin. Thrombosis Research. 44(6). 739–748. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact